Report Overview
The Global Spine Biologics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the spine biologics industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The spine biologics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The spine biologics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 276 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table Of Contents
Table of Contents
1 Industry Overview 1
1.1 Definition and Specifications of Spine Biologics 1
1.1.1 Definition of Spine Biologics 1
1.1.2 Specifications of Spine Biologics 2
1.2 Classification of Spine Biologics 3
1.2.1 Bone Graft 4
1.2.2 Bone Graft Substitute 4
1.2.3 Platelet Rich Plasma 5
1.2.4 BMAC 5
1.3 Applications of Spine Biologics 6
1.3.1 Anterior Cervical Discectomy and Fusion 7
1.3.2 Posterior Lumbar Interbody Fusion 7
1.4 Industry Chain Structure of Spine Biologics 8
1.5 Industry Overview and Major Regions Status of Spine Biologics 8
1.5.1 Industry Overview of Spine Biologics 8
1.5.2 Global Major Regions Status of Spine Biologics 9
1.6 Industry Policy Analysis of Spine Biologics 10
1.7 Industry News Analysis of Spine Biologics 12
2 Manufacturing Cost Structure Analysis of Spine Biologics 15
2.1 Raw Material Suppliers Analysis of Spine Biologics 15
2.2 Equipment Suppliers Analysis of Spine Biologics 16
2.3 Labor Cost Analysis of Spine Biologics 16
2.4 Other Costs Analysis of Spine Biologics 19
2.5 Manufacturing Cost Structure Analysis of Spine Biologics 20
2.6 Manufacturing Process Analysis of Spine Biologics 21
3 Technical Data and Manufacturing Plants Analysis 22
3.1 Capacity of Global Key Manufacturers in 2015 22
3.2 Key Manufacturing Plants Distribution of Global Key Spine Biologics Manufacturers in 2015 22
3.3 R&D Status and Technology Source of Global Spine Biologics Key Manufacturers in 2015 23
4 Capacity, Production and Revenue Analysis of Spine Biologics by Regions, Types and Manufacturers 24
4.1 Global Capacity, Production and Revenue of Spine Biologics by Regions 2011-2016 24
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Spine Biologics 2011-2016 27
4.3 Global Production and Revenue of Spine Biologics by Types 2011-2016 33
4.4 Global Capacity, Production and Revenue of Spine Biologics by Manufacturers 2011-2016 36
5 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Regions, Types and Manufacturers 43
5.1 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Regions 2011-2016 43
5.2 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Types 2011-2016 46
5.3 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Manufacturers 2011-2016 49
6 Consumption Volume, Consumption Value and Sale Price Analysis of Spine Biologics by Regions, Types and Applications 54
6.1 Global Consumption Volume and Consumption Value of Spine Biologics by Regions 2011-2016 54
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Spine Biologics 2011-2016 57
6.3 Global Consumption Volume and Consumption Value of Spine Biologics by Types 2011-2016 62
6.4 Global Consumption Volume and Consumption Value of Spine Biologics by Applications 2011-2016 65
6.5 Sale Price of Spine Biologics by Regions 2011-2016 68
6.6 Sale Price of Spine Biologics by Types 2011-2016 68
6.7 Sale Price of Spine Biologics by Applications 2011-2016 69
7 Supply, Import, Export and Consumption Analysis of Spine Biologics 70
7.1 Supply, Consumption and Gap of Spine Biologics 2011-2016 70
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 71
7.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 72
7.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 73
7.5 Asia Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 74
8 Analysis of Spine Biologics Industry Key Manufacturers 75
8.1 Medtronic 75
8.1.1 Company Profile 75
8.1.2 Product Information 76
8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 76
8.2 Depuy Synthes 78
8.2.1 Company Profile 78
8.2.2 Product Information 79
8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 80
8.3 Stryker Corporation 81
8.3.1 Company Profile 81
8.3.2 Product Information 82
8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 83
8.4 Nuvasive 84
8.4.1 Company Profile 84
8.4.2 Product Information 85
8.4.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 86
8.5 Zimmer Biomet 87
8.5.1 Company Profile 87
8.5.2 Product Information 88
8.5.3 Capacity, Production, Price, Cost, Gross, and Revenue 89
8.6 Orthofix International 90
8.6.1 Company Profile 90
8.6.2 Product Information 91
8.6.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 91
8.7 Globus Medical 93
8.7.1 Company Profile 93
8.7.2 Product Information 94
8.7.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 94
8.8 Alphatec spine 96
8.8.1 Company Profile 96
8.8.2 Product Information 97
8.8.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 97
8.9 K2M 99
8.9.1 Company Profile 99
8.9.2 Product Information 100
8.9.3 Capacity, Production, Price, Cost, Gross, and Revenue 100
8.10 Exactech 102
8.10.1 Company Profile 102
8.10.2 Product Information 103
8.10.3 Capacity, Production, Price, Cost, Gross, and Revenue 103
8.11 Wright Medical Technology 105
8.11.1 Company Profile 105
8.11.2 Product Information 106
8.11.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 106
8.12 X-Spine Systems 108
8.12.1 Company Profile 108
8.12.2 Product Information 109
8.12.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 109
8.13 Nutech 111
8.13.1 Company Profile 111
8.13.2 Product Information 112
8.13.3 Capacity, Production, Price, Cost, Gross, and Revenue 112
8.14 Arthrex 114
8.14.1 Company Profile 114
8.14.2 Product Information 115
8.14.3 Capacity, Production, Price, Cost, Gross, and Revenue 115
9 Marketing Trader or Distributor Analysis of Spine Biologics 117
9.1 Marketing Channels Status of Spine Biologics 117
9.2 Traders or Distributors with Contact Information of Spine Biologics 118
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Spine Biologics 119
9.4 Regional Import, Export and Trade Analysis of Spine Biologics 119
11 Development Trend of Analysis of Spine Biologics 121
11.1 Capacity, Production and Revenue Forecast of Spine Biologics by Regions and Types 121
11.1.1 Global Capacity, Production and Revenue of Spine Biologics by Regions 2016-2021 121
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Spine Biologics 2016-2021 124
11.1.3 Global Capacity, Production and Revenue of Spine Biologics by Types 2016-2021 129
11.2 Consumption Volume and Consumption Value Forecast of Spine Biologics by Regions, Types and Applications 132
11.2.1 Global Consumption Volume and Consumption Value of Spine Biologics by Regions 2016-2021 132
11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Spine Biologics 2016-2021 135
11.2.3 Global Consumption Volume and Consumption Value of Spine Biologics by Types 2016-2021 140
11.2.4 Global Consumption Volume and Consumption Value of Spine Biologics by Applications 2016-2021 143
11.3 Supply, Import, Export and Consumption Forecast of Spine Biologics 146
11.3.1 Supply, Consumption and Gap of Spine Biologics 2016-2021 146
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 147
11.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 148
11.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 148
11.3.5 Asia Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 149
12 New Project Investment Feasibility Analysis of Spine Biologics 150
12.1 New Project SWOT Analysis of Spine Biologics 150
12.2 New Project Investment Feasibility Analysis of Spine Biologics 150
12.2.1 Project Name 150
12.2.2 Investment Budget 150
12.2.3 Project Product Solutions 151
13 Conclusion of the Global Spine Biologics Industry 2016 Market Research Report 152
List Of Tables and Figures
Figure Picture of Spine Biologics 1
Table Comparison of Main Models from Spine Biologics Major Manufacturers 2
Table Specification of Main Models from Spine Biologics Major Brand 2
Table Specification Comparison of Different Types of Spine Biologics 3
Figure Global Production Market Share of Spine Biologics by Type in 2015 3
Figure Bone Graft Picture 4
Figure Bone Graft Substitute Picture 4
Figure Platelet Rich Plasma Picture 5
Figure BMAC Picture 5
Table Applications of Spine Biologics 6
Figure 2015 Global Spine Biologics Major Applications Sales Share 6
Figure Anterior Cervical Discectomy and Fusion Examples 7
Figure Posterior Lumbar Interbody Fusion Examples 7
Figure Industry Chain Structure of Spine Biologics 8
Table Global Spine Biologics Major Manufacturers 9
Table Global Major Regions Spine Biologics Production Market Share in 2015 9
Table Industry Policy of Spine Biologics 10
Table Industry News List of Spine Biologics 12
Table Raw Material Suppliers Analysis 15
Table Equipment Suppliers Analysis 16
Figure 2014 APAC Overview of Average Monthly Labor Cost 17
Figure 2014 Americas Overview of Average Monthly Labor Cost 17
Figure 2014 EMEA Overview of Average Monthly Labor Cost 18
Figure 2010-2015 USA Employment Cost Index (ECI) 18
Figure 2010-2014 China Average Wage of Worker and Growth Rate (CNY/a) 19
Table 2015 Electricity Price of Industry (USD/KW·h) by Some Country 19
Table Manufacturing Cost Structure Analysis of Spine Biologics in 2015 20
Figure Manufacturing Process Analysis of Spine Biologics 21
Table Capacity (K Units) of Global Spine Biologics Key Manufacturers in 2015 22
Table Key Manufacturing Plants Distribution of Global Spine Biologics Major Manufacturers in 2015 22
Table R&D Status and Technology Source of Global Spine Biologics Key Manufacturers in 2015 23
Table Global Capacity (K Units) of Spine Biologics by Regions 2011-2016 24
Figure Global Capacity Market Share of Spine Biologics by Regions in 2011 24
Figure Global Capacity Market Share of Spine Biologics by Regions in 2015 25
Table Global Production (K Units) of Spine Biologics by Regions 2011-2016 25
Figure Global Production Market Share of Spine Biologics by Regions in 2011 25
Figure Global Production Market Share of Spine Biologics by Regions in 2015 26
Table Global Revenue (M USD) of Spine Biologics by Regions 2011-2016 26
Figure Global Revenue Market Share of Spine Biologics by Regions in 2011 26
Figure Global Revenue Market Share of Spine Biologics by Regions in 2015 27
Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 27
Figure Global Capacity Utilization Rate of Spine Biologics 2011-2016 28
Figure Global Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 28
Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 29
Figure North America Capacity Utilization Rate of Spine Biologics 2011-2016 29
Figure North America Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 30
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 30
Figure Europe Capacity Utilization Rate of Spine Biologics 2011-2016 31
Figure Europe Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 31
Figure Asia Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 32
Figure Asia Capacity Utilization Rate of Spine Biologics 2011-2016 32
Figure Asia Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 33
Table Global Production (K Units) of Spine Biologics by Types 2011-2016 33
Figure Global Production Market Share of Spine Biologics by Types in 2011 34
Figure Global Production Market Share of Spine Biologics by Types in 2015 34
Table Global Revenue (M USD) of Spine Biologics by Types 2011-2016 35
Figure Global Revenue Market Share of Spine Biologics by Types in 2011 35
Figure Global Revenue Market Share of Spine Biologics by Types in 2015 36
Table Global and Major Manufacturers Capacity (K Units) of Spine Biologics 2011-2016 36
Table Global Capacity Market Share of Spine Biologics Major Manufacturers 2011-2016 37
Figure Global Capacity Market Share of Spine Biologics Major Manufacturers in 2011 37
Figure Global Capacity Market Share of Spine Biologics Major Manufacturers in 2015 38
Table Global and Major Manufacturers Production (K Units) of Spine Biologics 2011-2016 38
Table Global Production Market Share of Spine Biologics Major Manufacturers 2011-2016 39
Figure Global Production Market Share of Spine Biologics Major Manufacturers in 2011 39
Figure Global Production Market Share of Spine Biologics Major Manufacturers in 2015 40
Table Global and Major Manufacturers Revenue (M USD) of Spine Biologics 2011-2016 40
Table Global Revenue Market Share of Spine Biologics Major Manufacturers 2011-2016 41
Figure Global Revenue Market Share of Spine Biologics Major Manufacturers in 2011 41
Figure Global Revenue Market Share of Spine Biologics Major Manufacturers in 2015 42
Table Price (USD/Unit) of Spine Biologics by Regions 2011-2016 43
Figure Price (USD/Unit) of Spine Biologics by Regions in 2015 43
Table Cost (USD/Unit) of Spine Biologics by Regions 2011-2016 44
Figure Cost (USD/Unit) of Spine Biologics by Regions in 2015 44
Table Gross (USD/Unit) of Spine Biologics by Regions 2011-2016 44
Figure Gross (USD/Unit) of Spine Biologics by Regions in 2015 45
Table Gross Margin of Spine Biologics by Regions 2011-2016 45
Figure Gross Margin of Spine Biologics by Regions in 2015 45
Table Price (USD/Unit) of Spine Biologics by Types 2011-2016 46
Figure Price (USD/Unit) of Spine Biologics by Types in 2015 46
Table Cost (USD/Unit) of Spine Biologics by Types 2011-2016 46
Figure Cost (USD/Unit) of Spine Biologics by Types in 2015 47
Table Gross (USD/Unit) of Spine Biologics by Types 2011-2016 47
Figure Gross (USD/Unit) of Spine Biologics by Types in 2015 48
Table Gross Margin of Spine Biologics by Types 2011-2016 48
Figure Gross Margin of Spine Biologics by Types in 2015 49
Table Price (USD/Unit) of Spine Biologics by Manufacturers 2011-2016 49
Figure Price (USD/Unit) of Spine Biologics by Manufacturers in 2015 50
Table Cost (USD/Unit) of Spine Biologics by Manufacturers 2011-2016 50
Figure Cost (USD/Unit) of Spine Biologics by Manufacturers in 2015 51
Table Gross (USD/Unit) of Spine Biologics by Manufacturers 2011-2016 51
Figure Gross (USD/Unit) of Spine Biologics by Manufacturers in 2015 52
Table Gross Margin of Spine Biologics by Manufacturers 2011-2016 52
Figure Gross Margin of Spine Biologics by Manufacturers in 2015 53
Table Global Consumption Volume (K Units) of Spine Biologics by Regions 2011-2016 54
Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2011 55
Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2015 55
Table Global Consumption Value (M USD) of Spine Biologics by Regions 2011-2016 56
Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2011 56
Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2015 57
Figure Global Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 57
Figure Global Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 58
Figure North America Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 58
Figure North America Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 59
Figure Europe Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 59
Figure Europe Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 60
Figure China Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 60
Figure China Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 61
Figure Asia (Ex. China) Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 61
Figure Asia (Ex. China) Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 62
Table Global Consumption Volume (K Units) of Spine Biologics by Types 2011-2016 62
Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2011 63
Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2015 63
Table Global Consumption Value (M USD) of Spine Biologics by Types 2011-2016 64
Figure Global Consumption Value Market Share of Spine Biologics by Types in 2011 64
Figure Global Consumption Value Market Share of Spine Biologics by Types in 2015 65
Table Global Consumption Volume (K Units) of Spine Biologics by Applications 2011-2016 65
Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2011 66
Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2015 66
Table Global Consumption Value (M USD) of Spine Biologics by Applications 2011-2016 67
Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2011 67
Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2015 68
Table Sale Price (USD/Unit) of Spine Biologics by Regions 2011-2016 68
Table Sale Price (USD/Unit) of Spine Biologics by Types 2011-2016 68
Table Sale Price (USD/Unit) of Spine Biologics by Applications 2011-2016 69
Table Global Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70
Table North America Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70
Table Europe Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70
Table Asia Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 71
Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 71
Table North America Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 72
Table North America Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 72
Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 73
Table Europe Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 73
Table Asia Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 74
Table Asia Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 74
Table Medtronic Company Profile 75
Figure Spine Biologics Product Picture of Medtronic 76
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Medtronic 2011-2016 76
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Medtronic 2011-2016 77
Figure Spine Biologics Production (K Units) and Global Market Share of Medtronic 2011-2016 77
Table Depuy Synthes Company Profile 78
Figure Spine Biologics Product Picture of Depuy Synthes 79
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Depuy Synthes 2011-2016 80
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Depuy Synthes 2011-2016 80
Figure Spine Biologics Production (K Units) and Global Market Share of Depuy Synthes 2011-2016 81
Table Stryker Corporation Company Profile 81
Figure Spine Biologics Product Picture of Stryker Corporation 82
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Stryker Corporation 2011-2016 83
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Stryker Corporation 2011-2016 83
Figure Spine Biologics Production (K Units) and Global Market Share of Stryker Corporation 2011-2016 84
Table Nuvasive Company Profile 84
Figure Spine Biologics Product Picture of Nuvasive 85
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nuvasive 2011-2016 86
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Nuvasive 2011-2016 86
Figure Spine Biologics Production (K Units) and Global Market Share of Nuvasive 2011-2016 87
Table Zimmer Biomet Company Profile 87
Figure Spine Biologics Product Picture of Zimmer Biomet 88
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Zimmer Biomet 2011-2016 89
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Zimmer Biomet 2011-2016 89
Figure Spine Biologics Production (K Units) and Global Market Share of Zimmer Biomet 2011-2016 90
Table Orthofix International Company Profile 90
Figure Spine Biologics Product Picture of Orthofix International 91
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Orthofix International 2011-2016 91
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Orthofix International 2011-2016 92
Figure Spine Biologics Production (K Units) and Global Market Share of Orthofix International 2011-2016 92
Table Globus Medical Company Profile 93
Figure Spine Biologics Product Picture of Globus Medical 94
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Globus Medical 2011-2016 94
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Globus Medical 2011-2016 95
Figure Spine Biologics Production (K Units) and Global Market Share of Globus Medical 2011-2016 95
Table Alphatec spine Company Profile 96
Figure Spine Biologics Product Picture of Alphatec spine 97
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alphatec spine 2011-2016 97
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Alphatec spine 2011-2016 98
Figure Spine Biologics Production (K Units) and Global Market Share of Alphatec spine 2011-2016 98
Table K2M Company Profile 99
Figure Spine Biologics Product Picture of K2M 100
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of K2M 2011-2016 100
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of K2M 2011-2016 101
Figure Spine Biologics Production (K Units) and Global Market Share of K2M 2011-2016 101
Table Exactech Company Profile 102
Figure Spine Biologics Product Picture of Exactech 103
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Exactech 2011-2016 103
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Exactech 2011-2016 104
Figure Spine Biologics Production (K Units) and Global Market Share of Exactech 2011-2016 104
Table Wright Medical Technology Company Profile 105
Figure Spine Biologics Product Picture of Wright Medical Technology 106
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Wright Medical Technology 2011-2016 106
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Wright Medical Technology 2011-2016 107
Figure Spine Biologics Production (K Units) and Global Market Share of Wright Medical Technology 2011-2016 107
Table X-Spine Systems Company Profile 108
Figure Spine Biologics Product Picture of X-Spine Systems 109
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of X-Spine Systems 2011-2016 109
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of X-Spine Systems 2011-2016 110
Figure Spine Biologics Production (K Units) and Global Market Share of X-Spine Systems 2011-2016 110
Table Nutech Company Profile 111
Figure Spine Biologics Product Picture of Nutech 112
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nutech 2011-2016 112
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Nutech 2011-2016 113
Figure Spine Biologics Production (K Units) and Global Market Share of Nutech 2011-2016 113
Table Arthrex Company Profile 114
Figure Spine Biologics Product Picture of Arthrex 115
Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Arthrex 2011-2016 115
Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Arthrex 2011-2016 116
Figure Spine Biologics Production (K Units) and Global Market Share of Arthrex 2011-2016 116
Figure Marketing Channels of Spine Biologics 117
Table Traders or Distributors with Contact Information of Spine Biologics 118
Figure Ex-work Price, Channel Price and End Buyer Price of Spine Biologics (USD/Unit) in 2015 119
Table Regional Import, Export, and Trade of Spine Biologics (K Units) 119
Table Global Capacity (K Units) of Spine Biologics by Regions 2016-2021 121
Figure Global Capacity Market Share of Spine Biologics by Regions in 2016 121
Figure Global Capacity Market Share of Spine Biologics by Regions in 2021 122
Table Global Production (K Units) of Spine Biologics by Regions 2016-2021 122
Figure Global Production Market Share of Spine Biologics by Regions in 2016 122
Figure Global Production Market Share of Spine Biologics by Regions in 2021 123
Table Global Revenue (M USD) of Spine Biologics by Regions 2016-2021 123
Figure Global Revenue Market Share of Spine Biologics by Regions in 2016 123
Figure Global Revenue Market Share of Spine Biologics by Regions in 2021 124
Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 124
Figure Global Capacity Utilization Rate of Spine Biologics 2016-2021 124
Figure Global Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 124
Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 125
Figure North America Capacity Utilization Rate of Spine Biologics 2016-2021 125
Figure North America Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 126
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 126
Figure Europe Capacity Utilization Rate of Spine Biologics 2016-2021 127
Figure Europe Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 127
Figure Asia Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 128
Figure Asia Capacity Utilization Rate of Spine Biologics 2016-2021 128
Figure Asia Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 129
Table Global Production (K Units) of Spine Biologics by Types 2016-2021 129
Figure Global Production Market Share of Spine Biologics by Types in 2016 130
Figure Global Production Market Share of Spine Biologics by Types in 2021 130
Table Global Revenue (M USD) of Spine Biologics by Types 2016-2021 131
Figure Global Revenue Market Share of Spine Biologics by Types in 2016 131
Figure Global Revenue Market Share of Spine Biologics by Types in 2021 132
Table Global Consumption Volume (K Units) of Spine Biologics by Regions 2016-2021 132
Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2016 133
Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2021 133
Table Global Consumption Value (M USD) of Spine Biologics by Regions 2016-2021 134
Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2016 134
Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2021 135
Figure Global Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 135
Figure Global Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 136
Figure North America Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 136
Figure North America Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 137
Figure Europe Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 137
Figure Europe Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 138
Figure China Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 138
Figure China Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 139
Figure Asia (Ex. China) Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 139
Figure Asia (Ex. China) Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 140
Table Global Consumption Volume (K Units) of Spine Biologics by Types 2016-2021 140
Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2016 141
Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2021 141
Table Global Consumption Value (M USD) of Spine Biologics by Types 2016-2021 142
Figure Global Consumption Value Market Share of Spine Biologics by Types in 2016 142
Figure Global Consumption Value Market Share of Spine Biologics by Types in 2021 143
Table Global Consumption Volume (K Units) of Spine Biologics by Applications 2016-2021 143
Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2016 144
Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2021 144
Table Global Consumption Value (M USD) of Spine Biologics by Applications 2016-2021 145
Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2016 145
Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2021 146
Table Global Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 146
Table North America Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 147
Table Europe Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 147
Table Asia Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 147
Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 147
Table North America Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 148
Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 148
Table Asia Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 149
Table New Project SWOT Analysis of Spine Biologics 150
Table Project Appraisal and Financing 151
Table New Project Investment Feasibility Analysis of Spine Biologics 151